abstract |
The present invention relates to novel compounds of formula (I) and pharmaceutical compositions thereof, as well as methods for inhibiting the activity of phosphatase SHP2 using the compounds and compositions of the invention. The present invention further relates, but not limited to, methods of treating disorders associated with dysregulation of SHP2 with the compounds and compositions of the invention. |